Global Soluble Microneedle Market Growth 2025-2031

The global Soluble Microneedle market size is predicted to grow from US$ 49.8 million in 2025 to US$ 73.6 million in 2031; it is expected to grow at a CAGR of 6.7% from 2025 to 2031.

Soluble microneedle is a drug delivery system (DDS) that promotes penetration of drugs and active ingredients into the body safely and efficiently. Soluble microneedles are made by mixing active ingredients with dissolvable polymers to create a micron-sized needle shape that naturally dissolves away after skin insertion. These offer various advantages: First, the microneedle is a less painful way of delivering active ingredients compared with the syringe. This can potentially improve the quality of life for those who would otherwise need frequent injections. Second, the dissolvable microneedle is an environmentally friendly solution, leaving no dangerous or wasteful products behind, such as needles or glass, because microneedles dissolve into the skin after insertion. Third, cold-chain supply costs are reduced, because the solid state of the dissolvable microneedle enables greater stability during the distribution of various biopharmaceuticals without the need for refrigeration.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

LP Information, Inc. (LPI) ' newest research report, the “Soluble Microneedle Industry Forecast” looks at past sales and reviews total world Soluble Microneedle sales in 2024, providing a comprehensive analysis by region and market sector of projected Soluble Microneedle sales for 2025 through 2031. With Soluble Microneedle sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Soluble Microneedle industry.

This Insight Report provides a comprehensive analysis of the global Soluble Microneedle landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Soluble Microneedle portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Soluble Microneedle market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Soluble Microneedle and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Soluble Microneedle.

This report presents a comprehensive overview, market shares, and growth opportunities of Soluble Microneedle market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

Water-soluble Hyaluronic Acid Type

Cross-linked Hyaluronic Acid Type

Segmentation by Application:

Medical

Cosmetic

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

CosMED Pharmaceutical

Nissha Co.

Micron Biomedical

Bela LAB

Skyn ICELAND

Raphas

Dermaject

Shiseido Company

111Skin

Peace Out

Hero Cosmetics

Beauty Recipe

Youwe Biotechnology

Qinglan Biological

Lanwei Medicine

Key Questions Addressed in this Report

What is the 10-year outlook for the global Soluble Microneedle market?

What factors are driving Soluble Microneedle market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Soluble Microneedle market opportunities vary by end market size?

How does Soluble Microneedle break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.